A detailed history of Capital Advisors, Ltd. LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 190 shares of PRPH stock, worth $794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190
Previous 178 6.74%
Holding current value
$794
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$4.47 - $6.47 $53 - $77
12 Added 6.74%
190 $1,000
Q4 2023

Feb 02, 2024

BUY
$4.35 - $5.1 $382 - $448
88 Added 97.78%
178 $1,000
Q3 2023

Oct 27, 2023

BUY
$4.23 - $7.53 $380 - $677
90 New
90 $0

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $67M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.